Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Investors Lab
  • Published:

When your stock takes a nosedive

Nature Biotechnology volume 24, page 144 (2006)Cite this article

You've done your homework, studied a company's drugs in development and on the market, assessed the risks, checked its finances and arrived at an investment thesis. You estimate good potential returns and buy happily. But later, the stock drops significantly—perhaps 20%. Although you know you can't catch the low or high on a stock, this shakes you up. But fear not! With this guide, you can take sound action without panic.

What happened?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Author notes

  1. Tom Jacobs is cofounder of Complete Growth Investor, a stock service for individual investors. Tom owned shares of QLT at time of writing. He welcomes your comments at

    • Tom Jacobs
Authors
  1. Tom Jacobs
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacobs, T. When your stock takes a nosedive. Nat Biotechnol 24, 144 (2006). https://doi.org/10.1038/nbt0206-144

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0206-144

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing